GB9818938D0 - Bioactive peptides - Google Patents

Bioactive peptides

Info

Publication number
GB9818938D0
GB9818938D0 GBGB9818938.4A GB9818938A GB9818938D0 GB 9818938 D0 GB9818938 D0 GB 9818938D0 GB 9818938 A GB9818938 A GB 9818938A GB 9818938 D0 GB9818938 D0 GB 9818938D0
Authority
GB
United Kingdom
Prior art keywords
well
bioactive peptides
peptides
medicaments
cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818938.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals AS
Original Assignee
Alpharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma AS filed Critical Alpharma AS
Priority to GBGB9818938.4A priority Critical patent/GB9818938D0/en
Publication of GB9818938D0 publication Critical patent/GB9818938D0/en
Priority to EP99941774A priority patent/EP1109827B1/en
Priority to AU55267/99A priority patent/AU772176B2/en
Priority to CA2341037A priority patent/CA2341037C/en
Priority to DK99941773.6T priority patent/DK1109831T3/da
Priority to JP2000567559A priority patent/JP5475937B2/ja
Priority to PCT/GB1999/002850 priority patent/WO2000012541A2/en
Priority to DE69943130T priority patent/DE69943130D1/de
Priority to EP99941773A priority patent/EP1109831B1/en
Priority to AU55268/99A priority patent/AU5526899A/en
Priority to CA002340326A priority patent/CA2340326A1/en
Priority to AT99941774T priority patent/ATE513847T1/de
Priority to PCT/GB1999/002851 priority patent/WO2000012542A2/en
Priority to AT99941773T priority patent/ATE495192T1/de
Priority to ES99941773T priority patent/ES2359616T3/es
Priority to NO20010995A priority patent/NO333073B1/no
Priority to US09/798,869 priority patent/US6890902B2/en
Priority to US09/798,026 priority patent/US7439228B2/en
Priority to US11/726,172 priority patent/US8283315B2/en
Priority to US12/217,160 priority patent/US8143211B2/en
Priority to US13/585,232 priority patent/US9109048B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
GBGB9818938.4A 1998-08-21 1998-08-28 Bioactive peptides Ceased GB9818938D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9818938.4A GB9818938D0 (en) 1998-08-28 1998-08-28 Bioactive peptides
ES99941773T ES2359616T3 (es) 1998-08-28 1999-08-31 Péptidos citotóxicos modificados por restos voluminosos o lipofílicos.
CA002340326A CA2340326A1 (en) 1998-08-28 1999-08-31 Bioactive peptides
PCT/GB1999/002851 WO2000012542A2 (en) 1998-08-28 1999-08-31 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
CA2341037A CA2341037C (en) 1998-08-28 1999-08-31 Bioactive peptides
DK99941773.6T DK1109831T3 (da) 1998-08-28 1999-08-31 Cytotoksiske peptider modificeret ved store eller lipofile dele
JP2000567559A JP5475937B2 (ja) 1998-08-28 1999-08-31 生物活性ペプチド
PCT/GB1999/002850 WO2000012541A2 (en) 1998-08-28 1999-08-31 Cytotoxic peptides modified by bulky or lipophilic moieties
DE69943130T DE69943130D1 (de) 1998-08-28 1999-08-31 Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide
EP99941773A EP1109831B1 (en) 1998-08-28 1999-08-31 Cyctotoxic peptides modified by bulky or lipophilic moieties
AU55268/99A AU5526899A (en) 1998-08-28 1999-08-31 Bioactive peptides
EP99941774A EP1109827B1 (en) 1998-08-28 1999-08-31 Bioactive peptides
AT99941774T ATE513847T1 (de) 1998-08-28 1999-08-31 Bioaktive peptide
AU55267/99A AU772176B2 (en) 1998-08-28 1999-08-31 Bioactive peptides
AT99941773T ATE495192T1 (de) 1998-08-28 1999-08-31 Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide
US09/798,026 US7439228B2 (en) 1998-08-28 2001-02-27 Bioactive peptides
NO20010995A NO333073B1 (no) 1998-08-28 2001-02-27 Cytotoksiske peptider modifisert med en eller flere ikke-genetiske, voluminose og/eller lipofile aminosyrer.
US09/798,869 US6890902B2 (en) 1998-08-28 2001-02-27 Cytotoxic modified lactoferrin peptides
US11/726,172 US8283315B2 (en) 1998-08-28 2007-03-21 Inhibition of tumour growth
US12/217,160 US8143211B2 (en) 1998-08-28 2008-07-02 Bioactive peptides
US13/585,232 US9109048B2 (en) 1998-08-21 2012-08-14 Inhibition of tumor growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818938.4A GB9818938D0 (en) 1998-08-28 1998-08-28 Bioactive peptides

Publications (1)

Publication Number Publication Date
GB9818938D0 true GB9818938D0 (en) 1998-10-21

Family

ID=10838089

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818938.4A Ceased GB9818938D0 (en) 1998-08-21 1998-08-28 Bioactive peptides

Country Status (12)

Country Link
US (3) US6890902B2 (https=)
EP (2) EP1109827B1 (https=)
JP (1) JP5475937B2 (https=)
AT (2) ATE513847T1 (https=)
AU (2) AU5526899A (https=)
CA (2) CA2340326A1 (https=)
DE (1) DE69943130D1 (https=)
DK (1) DK1109831T3 (https=)
ES (1) ES2359616T3 (https=)
GB (1) GB9818938D0 (https=)
NO (1) NO333073B1 (https=)
WO (2) WO2000012541A2 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
KR20020080731A (ko) * 2001-04-17 2002-10-26 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 락토페리신 발현용형질전환체
KR100454595B1 (ko) * 2001-11-30 2004-10-28 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 형질전환 대장균
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
CN100467059C (zh) 2002-05-10 2009-03-11 阿根尼克斯有限公司 乳铁蛋白在治疗恶性肿瘤疾病中的用途
CA2490290A1 (en) * 2002-06-28 2004-01-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
US8105615B2 (en) * 2003-06-06 2012-01-31 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
CA2533753C (en) * 2004-03-19 2012-10-16 Morinaga Milk Industry Co., Ltd. Drug for cancer therapy
US8202841B2 (en) * 2004-06-17 2012-06-19 Mannkind Corporation SSX-2 peptide analogs
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
WO2006054908A1 (en) * 2004-11-19 2006-05-26 Fonterra Corporate Research And Development Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
WO2007055578A1 (en) * 2005-11-11 2007-05-18 Leids Universitair Medisch Centrum Cyclic antimicrobial peptides derived from lactoferrin
PL1966240T6 (pl) 2005-12-30 2012-05-31 Evonik Roehm Gmbh Peptydy laktoferyny użyteczne jako peptydy penetrujące komórkę
ES2321358B1 (es) * 2006-04-05 2010-03-05 Consejo Susperior De Investigaciones Cientificas Uso de peptidos derivados de la lactoferrina para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i.
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US7960339B2 (en) 2006-07-10 2011-06-14 Österreichische Akademie der Wissenschaften Antimicrobial peptides
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
EP2754450A1 (en) * 2013-01-11 2014-07-16 Österreichische Akademie der Wissenschaften Lactoferricin derived peptides
GB201401877D0 (en) 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN106794218A (zh) * 2014-10-08 2017-05-31 学校法人庆应义塾 白细胞的细胞外诱捕网形成抑制剂
ITUB20153058A1 (it) * 2015-08-11 2017-02-11 Farmagens Health Care S R L Roma ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
US11213512B2 (en) 2016-06-21 2022-01-04 The Curators Of The University Of Missouri Bis-amino acid based compound and use thereof
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
US11364275B2 (en) 2017-08-04 2022-06-21 Bioventures, Llc Linear lipopeptide paenipeptins and methods of using the same
US11236138B2 (en) * 2020-01-14 2022-02-01 Renorigin Innovation Institute Co., Ltd. Peptide, method and composition for melanin polymerization and hair darkening
CN115073352A (zh) * 2022-06-28 2022-09-20 吉尔多肽生物制药(大连市)有限公司 一种2,5,7-三叔丁基色氨酸的合成方法
CN121086066A (zh) * 2024-12-19 2025-12-09 合肥工业大学 牛乳铁蛋白多肽及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141581A (en) * 1972-10-08 1992-08-25 Markham Harold A Implants with a cover which resists formation of firm spherical encapsulation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US5073542A (en) 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus
DK167813B1 (da) 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
NZ241936A (en) * 1991-03-13 1994-03-25 Morinaga Milk Industry Co Ltd Antimicrobial peptide and its use in an antimicrobial composition
CA2111214A1 (en) * 1991-06-12 1992-12-23 W. Lee Maloy Composition and treatment with biologically active peptides having c-terminal substitutions
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US5631228A (en) * 1991-11-01 1997-05-20 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
DK0629347T3 (da) 1992-01-23 1998-02-16 Morinaga Milk Industry Co Ltd Antibakterielt middel og behandling af genstande dermed
EP0644769A4 (en) * 1992-06-01 1995-08-09 Magainin Pharma BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
AU673190B2 (en) * 1992-07-13 1996-10-31 Bionebraska, Inc. Method for modification of recombinant polypeptides
US5593866A (en) 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
WO1994012206A1 (en) 1992-12-03 1994-06-09 Magainin Pharmaceuticals, Inc. Treatment of dermatological malignancies with biologically active peptides
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
CA2262429A1 (en) * 1996-08-14 1998-02-19 Novartis Ag Peptide with inhibitory activity towards plant pathogenic fungi
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO1998040091A1 (en) * 1997-03-13 1998-09-17 The Research Foundation Of State University Of New York Microbicidal peptides and methods of use
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
JP5475937B2 (ja) 2014-04-16
DK1109831T3 (da) 2011-04-18
EP1109831A2 (en) 2001-06-27
US20080287346A1 (en) 2008-11-20
US20030148936A1 (en) 2003-08-07
ATE495192T1 (de) 2011-01-15
NO20010995D0 (no) 2001-02-27
EP1109831B1 (en) 2011-01-12
JP2002523517A (ja) 2002-07-30
WO2000012541A2 (en) 2000-03-09
NO20010995L (no) 2001-04-27
WO2000012541A3 (en) 2000-06-08
US7439228B2 (en) 2008-10-21
AU772176B2 (en) 2004-04-08
CA2340326A1 (en) 2000-03-09
NO333073B1 (no) 2013-02-25
WO2000012542A3 (en) 2000-06-29
ATE513847T1 (de) 2011-07-15
EP1109827B1 (en) 2011-06-22
AU5526899A (en) 2000-03-21
DE69943130D1 (de) 2011-02-24
ES2359616T3 (es) 2011-05-25
US6890902B2 (en) 2005-05-10
EP1109827A2 (en) 2001-06-27
CA2341037A1 (en) 2000-03-09
AU5526799A (en) 2000-03-21
CA2341037C (en) 2013-11-05
US8143211B2 (en) 2012-03-27
US20030022821A1 (en) 2003-01-30
WO2000012542A2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
GB9818938D0 (en) Bioactive peptides
IL139825A0 (en) Novel cyclosporins
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
GEP20053473B (en) High Potency Dihydroergotamine Compositions
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
GR3024495T3 (en) Cyclic peptides and use thereof
ATE317846T1 (de) Phosphoramidat-prodrugs
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DK1313440T3 (da) Dentalprodukter indeholdende knoglevækstforögende peptider
FR2741076B1 (fr) Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
MXPA01011955A (es) Aminoacidos policiclicos, fusionados, como agentes farmaceuticos.
AU3739500A (en) Protease resistant flint analogs
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
MY129892A (en) The meglumine salt of a 1,2,3,4-tetrahydro-2-quinoline carboxylic acid
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
AP1734A (en) Crystalline forms of 1S-[1alpha(2S*,3*), 9 alpha]-6, 10-dioxo-N-(2-ethoxy-5- oxo-tetrahydro-3-furanyl)-9-[[(isoquinolyl) carbonyl]-amino] octahydro-6H-piridazino[1,2-A][1,2] diazepin- 1-carboxamide.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)